Since December 2020, four vaccines for SARS-CoV-2 (severe acute respiratory syndrome
coronavirus 2) have been developed, and three have been approved for immediate use in
the United States. Two are mRNA vaccines, and one uses a viral vector mechanism.
Thrombotic complications have been reported after vaccine administration, which were
primarily cerebral sinus thromboses after administration of the viral vector vaccines. To the
best of our knowledge, we are the first to report venous thrombotic complications within days …